According to Precision Business Insights, the Dermal Fillers Market research report provides industry size and growth.
According to Precision Business Insights (PBI), the latest report the global dermal fillers market is expected to be worth USD 2,500 million in 2022 and projected to grow at 10% CAGR from 2023 to 2029. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. The global dermal fillers market was valued at US$ 3.2 Bn in 2017 and growing at a significant CAGR over the forecast period owing to increase in the number patients with different cosmetic skin issues like deep lines, wrinkles and scars around the globe. Additionally, rise in number of geriatric population, rise in preference for minimally invasive or non-invasive surgical procedures, and fast and ease of treatment are anticipated to propel the global dermal fillers market. However, high cost for the dermal fillers procedure and post-procedure complications are expected to hinder the growth of global dermal fillers market over forecast years.
The global dermal fillers market segmented on the basis of product type, ingredient type, distribution channel, and region
Based on product type, global dermal fillers market segmented into absorbable dermal fillers and non-absorbable dermal fillers. Absorbable dermal fillers market accounted for larger revenue share in 2017 and projected to dominate over the forecast period owing to growing adoption by patients and its safety profile. Moreover, absorbable dermal fillers segment projected exhibit lucrative growth, which is mainly attributed to non-invasive or minimally invasive treatment procedure and low cost of the treatment.
North America leads the Global Dermal Fillers market
PBI'™s global dermal fillers market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America accounted for larger revenue share through 2012-2017 and the same trend is projected to follow over 2018-2023 owing to increase in the preference for non-invasive aesthetic procedures, rise in geriatric population, and increase in disposable income.
Launch of newer products, frequent product approvals, and strategic alliances are the key strategies adopted by market players
Global dermal fillers market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance. In 2015, Allergan plc, received approval from the U.S.FDA approval to market its juvederm ultra XC injection used for lip augmentation in adults over the age of 21
Key player'™s profiles in the report are Galderma (Nestle) (Switzerland), MERZ PHARMA GMBH & CO. KGAA (Germany), and Allergan plc (Ireland)
Request Sample: https://www.precisionbusinessinsights.com/request-sample/?product_id=51456
Detailed Segmentation
By Product Type
By Ingredient Type
By Distribution Channel
Geography